A Randomized, Double-Blind, Placebo-Controlled, Clinical Food Trial of Probiotic/Prebiotic Medical Food for the Dietary Management of Age Related Bone Loss

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized, double blind, placebo controlled clinical trial will test the efficacy of a probiotic/prebiotic combination (synbiotic) on the skeleton in older women.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 60
Healthy Volunteers: t
View:

• Provide written informed consent

• Stated availability throughout entire study period and willingness to fulfill all details of the protocol

• Age 60 years and above

• DXA-BMD of the hip and spine (T-score) \> -2.5. Women with a BMD T score ≤ -2.5 (i.e. women with low BMD indicating osteoporosis) will also be considered if they have decided not to accept the standard of care with use of osteoporosis medications for the entire duration of their participation in the study.

• 25-hydroxy vitamin D ≥ 20 ng/mL

• Normal renal function (eGFR \>50 ml/min)

• Have chosen to not accept the standard of care with use of osteoporosis medications for the duration of the study.

• Willing to comply with protocol and report on compliance and side effects during study period.

Locations
United States
Massachusetts
Hebrew SeniorLife
RECRUITING
Roslindale
Contact Information
Primary
Shivani Sahni, PhD
ShivaniSahni@hsl.harvard.edu
617-971-5382
Backup
Evelyn O'Neill
oneill@hsl.harvard.edu
617-697-6599
Time Frame
Start Date: 2024-08-12
Estimated Completion Date: 2028-04
Participants
Target number of participants: 220
Treatments
Experimental: SBD111 medical food
This group will receive SBD111 medical food capsules to be consumed over 18 months.
Placebo_comparator: Placebo
This group will receive placebo capsules to be consumed over 18 months.
Related Therapeutic Areas
Sponsors
Leads: Hebrew SeniorLife
Collaborators: MaineHealth, Solarea Bio, Inc, Tufts University, Beth Israel Deaconess Medical Center

This content was sourced from clinicaltrials.gov